Skip to main content
Skip to primary sidebar
Skip to footer
About
Our Value
Services
Competitive Intelligence
Business Development
Forecasting
Research
Publications
FDA Approvals
Contact
Approvals
Approvals
Tepmetko is the new FDA approved Only Once-daily oral drug for Aggressive Metastatic NSCLC patients
New FDA approved Cabenuva treatment regiment for HIV-1 Patients
FDA approved the supplemental new drug application for Xalkori for pediatric ALCL patients
FDA New Drug Therapies Approval 2015 – Present
53 New Drug Therapy Approvals by the FDA in 2020
Checkout out our latest research here
Research Store
